Tenet Healthcare (THC) Tops Q3 EPS by 36c; offers guidance
Tenet Healthcare (NYSE: THC) reported Q3 EPS of $3.70, $0.36 better than the analyst estimate of $3.34. Revenue for the quarter came in at $5.29 billion versus the consensus estimate of $5.26 billion.
GUIDANCE:
Tenet Healthcare sees FY2025 EPS of $15.93-$16.26, versus the consensus of $15.83. Tenet Healthcare sees FY2025 revenue of $21.15-21.35 billion, versus the consensus of $21.147 billion.
For earnings history and earnings-related data on Tenet Healthcare (THC) click here.
